Hapa Onur, Karakaşlı Ahmet, Demirkıran Nihat Demirhan, Akdeniz Olcay, Havitçioğlu Hasan
Acta Orthop Belg. 2016 Mar;82(1):68-71.
Aim of the study was to review the radiological, clinical results of 11 chondroblastoma cases treated at our institute between 2003-2013. All patients with chondroblastoma included in this study underwent intra-lesional curettage+/-bone grafting. Follow up for healing of chondroblastoma lesions and detection of any local recurrence was assessed on clinical and radiological bases. The functional outcome was assessed by the Musculoskeletal Tumour Society scoring system. The mean follow-up period was 6.1 years. There were three recurrences (two femoral head, one proximal tibia). The mean Musculoskeletal Tumour Society functional score was 21. First line aggressive treatment seems appropriate for chondroblastoma especially when localized at lower extremities.
本研究的目的是回顾2003年至2013年间在我院接受治疗的11例软骨母细胞瘤病例的放射学和临床结果。本研究纳入的所有软骨母细胞瘤患者均接受了病灶内刮除术+/-植骨术。通过临床和放射学检查评估软骨母细胞瘤病灶的愈合情况以及是否存在局部复发。采用肌肉骨骼肿瘤学会评分系统评估功能结果。平均随访期为6.1年。有3例复发（2例位于股骨头，1例位于胫骨近端）。肌肉骨骼肿瘤学会的平均功能评分为21分。一线积极治疗似乎适用于软骨母细胞瘤，尤其是当病变位于下肢时。
